Achieve Life Sciences, Inc.
ACHV · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$14 | -$13 | -$13 | -$12 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $3 | $2 | $1 |
| Change in WC | $1 | $1 | -$1 | $1 |
| Other Non-Cash | $2 | $0 | $0 | $0 |
| Operating Cash Flow | -$11 | -$9 | -$11 | -$9 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$15 | -$1 | -$3 | -$1 |
| Inv. Sales/Matur. | $3 | $8 | $15 | $13 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$13 | $7 | $11 | $12 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $4 | $41 | $0 | -$56 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $57 |
| Financing Cash Flow | $4 | $41 | $0 | $1 |
| Forex Effect | -$0 | $0 | -$0 | -$0 |
| Net Chg. in Cash | -$20 | $39 | $0 | $3 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $52 | $13 | $13 | $10 |
| End Cash | $32 | $52 | $13 | $13 |
| Free Cash Flow | -$11 | -$9 | -$11 | -$9 |